Friday, 21 January 2022
  
Login

Australia's most trusted
source of pharma news

Friday, 21 January 2022
Ascott
Ascott
Latest News
Merck pips Novartis in MET race

Competition is heating up in Australia's MET inhibitor space for non-small cell lung cancer, with Merck scoring an early win as Novartis closes in.

Winners & losers in drug pricing
Survey reveals Aust pharmaceutical prices are going backwards
TODAY
Who's our top pharma employer?
One company makes prestigious list six years straight
TODAY
Aussie expat is new Vertex boss
First task, a controversial reimbursement battle
TODAY
Most Popular
Jobs shake-up at Merck
Head of Patient Services team made redundant in overhaul
20 January
Sanofi leader sues over job loss
Unfair dismissal claim after accusing a colleague of incompetence
19 January
MSLs ride salary boom
Aussies surge ahead in the global pay race
18 January
Roche leader switches camps
Aussie Biotech announces two new international hires
18 January
Latest Jobs
Pharma in Focus  Jobs

Marketing & Communications (8)

Sales & Customer Relations (25)

Access & Reimbursement (1)

Clinical & Medical, R&D (12)

Regulatory, Pharmacovigilance & QA (6)

Other (16)

More News
MA notches up a new member
First member admitted for 2022, the third in as many months
TODAY
AZ's Covid drug wins review
Preventative treatment could be a game-changer
TODAY
Pfizer faster than MSD on Covid pill
Same day approval but Pfizer nod took much less time
20 January
Novavax nod needs a boost
Off to a slow start with booster approval still pending
20 January
Blockbusters come knocking
TGA assessing two of seven 'most likely' billion-dollar products
20 January
J&J snags MSD manager
Internal promotion makes way for new hire in Gov't Affairs & Policy
20 January
Buy out boom forecast for 2022
Pharma goes shopping for new acquisitions to fuel growth
20 January
GSK plays hardball in sell-off
Three offers rejected holding out for a higher price
19 January
Covid vax battle not over
Call to be ready for new, more deadly variant
19 January
New CEO joins Aussie ranks
Industry veteran takes top job ahead of anticipated growth
19 January
Official PBS account up $1.5b
Special arrangement drugs saw strongest growth
19 January
TGA warns on cyber threat
Medicine sponsors considered vulnerable to hackers
19 January
What PBAC told Pfizer, Novartis, AZ
Latest documents reveal wrangling over new drug prices
18 January
Zejula cleared for PBAC
TGA nod opens treatment pathway to more patients
18 January
pif 20K
pif 20K
© 2003 - 2022 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe